TRP Channels as Therapeutic Targets in Diabetes and Obesity
AbstractDuring the last three to four decades the prevalence of obesity and diabetes mellitus has greatly increased worldwide, including in the United States. Both the short- and long-term forecasts predict serious consequences for the near future, and encourage the development of solutions for the prevention and management of obesity and diabetes mellitus. Transient receptor potential (TRP) channels were identified in tissues and organs important for the control of whole body metabolism. A variety of TRP channels has been shown to play a role in the regulation of hormone release, energy expenditure, pancreatic function, and neurotransmitter release in control, obese and/or diabetic conditions. Moreover, dietary supplementation of natural ligands of TRP channels has been shown to have potential beneficial effects in obese and diabetic conditions. These findings raised the interest and likelihood for potential drug development. In this mini-review, we discuss possibilities for better management of obesity and diabetes mellitus based on TRP-dependent mechanisms. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Zsombok, A.; Derbenev, A.V. TRP Channels as Therapeutic Targets in Diabetes and Obesity. Pharmaceuticals 2016, 9, 50.
Zsombok A, Derbenev AV. TRP Channels as Therapeutic Targets in Diabetes and Obesity. Pharmaceuticals. 2016; 9(3):50.Chicago/Turabian Style
Zsombok, Andrea; Derbenev, Andrei V. 2016. "TRP Channels as Therapeutic Targets in Diabetes and Obesity." Pharmaceuticals 9, no. 3: 50.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.